• Siga nossas redes sociais:
IUPHAR – Pharmacology International July 2020 IssueIUPHAR – Pharmacology International July 2020 IssueIUPHAR – Pharmacology International July 2020 IssueIUPHAR – Pharmacology International July 2020 Issue
Área do associado
  • Home
  • Institucional
    • Institucional
    • Diretoria
    • Diretorias Anteriores
    • Ata de Fundação
    • Estatuto
    • SBFTE Jovem
    • Edital SBFTE de apoio a Cursos em Farmacologia
    • Filie-se
    • Área do associado
  • Congressos
    • Congresso 2022
    • Congressos Anteriores
  • Iniciativas Educacionais
  • Notícias
  • Homenagens
  • Grupos de Trabalho
    • SIG Farmaco
    • Fórum de PG
  • English
  • Portuguese
✕
            Nenhum resultado Visualizar todos os resultados
            Sociedade Britânica de Farmacologia realizará congresso online
            20 de julho de 2020
            A CAPES emite carta em resposta ao Manifesto das Áreas de Avaliação da Capes
            21 de julho de 2020

            IUPHAR – Pharmacology International July 2020 Issue

            20 de julho de 2020
            Categorias
            • Sbfte
            Tags

            New edition of Pharmacology International. This issue is all about the Covid-19 pandemic that has been keeping the entire world, and of course science, in suspense for months.

            The pandemic poses a major challenge for the societies and science worldwide. The great uncertainty, especially at the beginning of the pandemic, in which the health care system of some countries was at the edge of its capacity, led to the great need – also among the public – for fast treatment approaches. As a result, the standards of clinical trials were not always met, and results that had not yet been secured prematurely became public, so that the hopes of some preparations were dashed at an early stage. Hydroxychloroquine is an example of this, which has not only caused no benefit so far, but turned out to be harmful. Studies on hydroxychloroquine have consequently been halted by WHO and FDA.

            It is the responsibility of experimental and clinical pharmacology to urge compliance with clinical and clinical trial standards if evidence of successful treatment of Covid-19 disease and SARS-CoV-2 infection should be reached. Several of IUPHAR’s member societies have published excellent statements in this direction. We as the umbrella organization of the global pharmacological societies offer a forum for our members on our homepage iuphar.org where you can find links to major contributions. Some are summarized here in Pharmacology International.

            Beyond Covid-19, I would like to draw your attention to the further activities of IUPHAR. The governance review report by Wellspring Consultants has been finalized. I would like to thank already at this stage all officers, members of the executive committee and chairs of the subcommittees as well as leaders of our member societies for their constructive comments.  IUPHAR has established working groups to set-up the new governance structure along the recommendations made in the review report under the professional guidance of Wellspring Consulting. Our stakeholders will be involved.

            More activities of and around IUPHAR can be found in this new edition of Pharmacology International.

            Best wishes and stay healthy.
            Yours,

            Ingolf Cascorbi
            IUPHAR President

            https://iuphar.org/

            • Facebook
            • Twitter
            • Instagram
            Compartilhar

            Mais publicações

            9 de janeiro de 2023

            SBFTE endossa nota da SBPC que repudia crimes contra a democracia


            Leia mais
            4 de janeiro de 2023

            SBFTE apoia a indicação de sua associada, Profa. Dra. Soraya Soubhi Smaili, à presidência do Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq)


            Leia mais
            29 de dezembro de 2022

            NOTA DE AGRADECIMENTO: Diretoria da SBFTE eleita para o triênio 2024-2026


            Leia mais
            Leia todas as notícias
            • 10 Anos do Glossário Semântico de Farmacologia da SBFTE
            • CONGRESSO 2023: Submissão de Sugestão de Atividade prorrogada até 30 de janeiro
            • Bolsa FAPESP para Treinamento Técnico Nível 3 (TT-3) na Faculdade de Ciências Farmacêuticas de Ribeirão Preto-USP
            • Congresso SBFTE 2023 – Formulários para sugestões de Atividades
            • Inscrições de propostas para Reunião da FESBE Ceará 2023

            Filiações

            Contato e Endereço

            Secretaria Executiva

            Sandra H. R. da Cruz
            Tel: (11) 2976-2793
            Celular/Whatsapp: (11) 99191-3794
            E-mail: sbfte@sbfte.org.br
            CNPJ: 49236359/0001-51

            Comunicação SBFTE

            (Para contato de divulgações e atendimento da imprensa)
            E-mail: sbftecomunicacao@gmail.com

            Todos os direitos reservados © SBFTE - Sociedade Brasileira de Farmacologia e Terapêutica Experimental
            Área do associado
            • Siga nossas redes sociais: